Developmental Funds Core
Developmental Funds Core
批准号:
10493591
负责人:
ANDREW K. GODWIN
金额:
$68.75万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-07-11 至 2027-06-30
关键词:
AppointmentAreaBasic ScienceBehavior TherapyCancer CenterCancer Center Support GrantCatchment AreaClinicalClinical ResearchClinical SciencesClinical TrialsDataDevelopmentDoctor of PhilosophyEnvironmentFaculty RecruitmentFundingFunding MechanismsGoalsGrantIncidenceIndividualInternationalInterventionInvestmentsKansasLeadershipMalignant NeoplasmsMentorsMindMorbidity - disease ratePatient-Focused OutcomesPilot ProjectsPopulation ResearchPopulation SciencesPositioning AttributeResearchResearch ActivityResearch PersonnelResearch Project GrantsResearch ProposalsResource SharingRuralRural PopulationScientistSpecial PopulationTestingTherapeutic InterventionTranslational ResearchUnderrepresented MinorityUnderrepresented PopulationsUniversitiesVisionanticancer researchbasedrug developmentdrug discoveryearly phase clinical trialfaculty supportflexibilityimprovedinnovationinterdisciplinary approachmortalityoutreachprecision medicineprogramsrecruit
中文摘要
医疗基金:摘要
堪萨斯大学癌症中心(KUCC)申请癌症中心支持补助金(CCSG)
发展基金,以支持试点研究项目,补充新的教师招聘包,
支持临床和特殊人群研究人员促进转化和临床科学
研究活动,并帮助将这些研究活动扩展到代表性不足的人群。供资试点
项目,招募新的教师,并支持工作人员调查将共同丰富研究工作
实现战略优先事项,提高KUCC服务癌症中心集水区的能力,
重要的是帮助减轻癌症在我们地区和全国的影响。KUCC领导层认为
CCSG发展基金支持的活动将使KUCC能够提供丰富的环境,
开发改变范式的疗法和干预措施,从而为多种和
跨学科团队赠款。这些资金将使我们能够专注于精准医疗的力量,
科学探究,药物发现和开发,以及降低癌症发病率的行为干预,
发病率和死亡率。此外,发展基金将帮助KUCC促进癌症中心文化
支持我们的最高优先级,即利用集体最先进的基础、临床、转化和
人口研究计划,以了解癌症在一个基本的水平,并催化一个全面的,
多学科方法,以改善患者的结果。KUCC在以下方面表现出了成功的业绩记录:
自接受CCSG发展基金和其他KUCC指导的资金机制以来,
2012年将获得NCI认证,并将继续从这些基金中获得强劲的投资回报。
英文摘要
DEVELOPMENTAL FUNDS: ABSTRACT
The University of Kansas Cancer Center (KUCC) requests Cancer Center Support Grant (CCSG)
Developmental Funds to support pilot research projects, supplement new faculty recruitment packages, and
support Clinical and Special Populations Staff Investigators to promote translational and clinical science
research activities and help extend those research activities to underrepresented populations. Funding pilot
projects, recruiting new faculty, and supporting Staff Investigators will collectively enrich research endeavors
towards strategic priorities, enhance the ability of KUCC to serve the Cancer Center’s catchment area, and
importantly help mitigate the impact of cancer in our region as well as nationally. KUCC leadership believes
that activities supported by CCSG Developmental Funds will enable KUCC to provide a rich environment to
develop paradigm-changing therapeutics and interventions, and thereby enable the funding of multi- and
transdisciplinary team-based grants. These funds will allow us to focus the power of precision medicine, basic
science inquiry, drug discovery and development, and behavioral interventions to decrease cancer incidence,
morbidity, and mortality. Furthermore, Developmental Funds will help KUCC promote a Cancer Center culture
that supports our highest priority of leveraging the collective state-of-the-art basic, clinical, translational and
population research programs to understand cancer at a fundamental level and catalyze a comprehensive,
multidisciplinary approach to improve patient outcomes. KUCC has demonstrated a successful track record in
its investment of CCSG Developmental Funds and other KUCC-directed funding mechanisms since receiving
NCI designation in 2012 and will continue to grow a strong return on investment from these funds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Kansas Institute for Precision Medicine : Zeiss Axioscan 7
-
批准号:10610667
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2022
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10526715
-
项目类别:
-
资助金额:$16.08万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10621734
-
项目类别:
-
资助金额:$59.3万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10373086
-
项目类别:
-
资助金额:$62.69万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10199594
-
项目类别:
-
资助金额:$65.55万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer
-
批准号:10307656
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10737826
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
The Kansas Institute for Precision Medicine
-
批准号:10582647
-
项目类别:
-
资助金额:$224.19万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
The Kansas Institute for Precision Medicine: IsoPlexis IsoSpark
-
批准号:10806784
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Administrative Core
-
批准号:10867199
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biobanking and Biomarker Validation (BBV) Core
-
批准号:10582682
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Administrative Core
-
批准号:10582668
-
项目类别:
-
资助金额:$94.92万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Administrative Core
-
批准号:10115107
-
项目类别:
-
资助金额:$49.34万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biobanking and Biomarker Validation (BBV) Core
-
批准号:10115115
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biospecimen Shared Resource
-
批准号:10493595
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biospecimen Shared Resource
-
批准号:9975733
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Developmental Funds Core
-
批准号:10671721
-
项目类别:
-
资助金额:$66.73万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biospecimen Shared Resource
-
批准号:10671734
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer
-
批准号:8444503
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2010
-
负责人:ANDREW K. GODWIN
-
依托单位:
Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer
-
批准号:8730322
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2010
-
负责人:ANDREW K. GODWIN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: